Karine Peignaux

1.2k total citations
46 papers, 617 citations indexed

About

Karine Peignaux is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Karine Peignaux has authored 46 papers receiving a total of 617 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 19 papers in Oncology and 16 papers in Surgery. Recurrent topics in Karine Peignaux's work include Breast Cancer Treatment Studies (11 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Advanced Radiotherapy Techniques (9 papers). Karine Peignaux is often cited by papers focused on Breast Cancer Treatment Studies (11 papers), Endometrial and Cervical Cancer Treatments (9 papers) and Advanced Radiotherapy Techniques (9 papers). Karine Peignaux collaborates with scholars based in France, United Kingdom and Germany. Karine Peignaux's co-authors include P. Maingon, G. Truc, G. Créhange, I. Barillot, Christine Haie-Méder, Alexandre Escande, C. Durdux, Franck Bonnetain, Cyrus Chargari and Sophie Renard and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Karine Peignaux

44 papers receiving 611 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karine Peignaux France 13 292 264 235 102 97 46 617
Mauricio Cambeiro Spain 16 298 1.0× 333 1.3× 289 1.2× 99 1.0× 182 1.9× 64 715
Sei‐Chul Yoon South Korea 15 223 0.8× 200 0.8× 204 0.9× 144 1.4× 109 1.1× 25 619
Chawalit Lertbutsayanukul Thailand 12 179 0.6× 118 0.4× 136 0.6× 159 1.6× 112 1.2× 50 500
Sonali Rudra United States 13 204 0.7× 112 0.4× 192 0.8× 50 0.5× 132 1.4× 24 498
Subhakar Mutyala United States 13 159 0.5× 181 0.7× 89 0.4× 89 0.9× 200 2.1× 43 525
John M. Stahl United States 11 161 0.6× 260 1.0× 186 0.8× 147 1.4× 65 0.7× 32 538
Noriko Ii Japan 13 185 0.6× 200 0.8× 146 0.6× 26 0.3× 73 0.8× 40 519
Sait Okkan Türkiye 15 183 0.6× 173 0.7× 189 0.8× 35 0.3× 130 1.3× 39 654
Ji Hyeon Joo South Korea 13 142 0.5× 151 0.6× 125 0.5× 37 0.4× 118 1.2× 53 463
Gaia Piperno Italy 15 106 0.4× 334 1.3× 172 0.7× 56 0.5× 153 1.6× 57 648

Countries citing papers authored by Karine Peignaux

Since Specialization
Citations

This map shows the geographic impact of Karine Peignaux's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karine Peignaux with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karine Peignaux more than expected).

Fields of papers citing papers by Karine Peignaux

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karine Peignaux. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karine Peignaux. The network helps show where Karine Peignaux may publish in the future.

Co-authorship network of co-authors of Karine Peignaux

This figure shows the co-authorship network connecting the top 25 collaborators of Karine Peignaux. A scholar is included among the top collaborators of Karine Peignaux based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karine Peignaux. Karine Peignaux is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Allodji, Rodrigue S., Sibille Everhard, Youlia Kirova, et al.. (2023). CANTO-RT: One of the Largest Prospective Multicenter Cohort of Early Breast Cancer Patients Treated with Radiotherapy including Full DICOM RT Data. Cancers. 15(3). 751–751. 6 indexed citations
2.
Antoni, D., L. Claude, Anne Laprie, et al.. (2022). Les essais qui changent les pratiques : le point en 2022. Cancer/Radiothérapie. 26(6-7). 823–833. 1 indexed citations
3.
Bertaut, Aurélie, Françoise Beltjens, Isabelle Desmoulins, et al.. (2021). Omitting axillary lymph node dissection after positive sentinel lymph node in the post-Z0011 era: Compliance with NCCN and ASCO clinical guidelines and Z0011 criteria in a large prospective cohort. Bulletin du Cancer. 109(3). 268–279. 3 indexed citations
4.
Chargari, Cyrus, Karine Peignaux, Alexandre Escande, et al.. (2021). Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology. Cancer/Radiothérapie. 26(1-2). 292–297. 3 indexed citations
5.
6.
Belin, Lisa, Paul Cottu, P. Bontemps, et al.. (2018). Evaluation at 3 years of concurrent bevacizumab and radiotherapy for breast cancer: Results of a prospective study. Cancer/Radiothérapie. 22(3). 222–228. 2 indexed citations
7.
Christodoulou, Maria, Fiona Blackhall, Linda Ashcroft, et al.. (2017). OA05.06 Compliance and Outcome of Elderly Patients Treated in the Concurrent Once-Daily versus Twice-Daily RadioTherapy (CONVERT) Trial. Journal of Thoracic Oncology. 12(1). S262–S263. 1 indexed citations
8.
Barillot, I., et al.. (2016). Radiothérapie des cancers du col et de l’endomètre. Cancer/Radiothérapie. 20. S189–S195. 11 indexed citations
9.
Belin, Lisa, P. Cottu, P. Bontemps, et al.. (2015). Late toxicities and outcomes of adjuvant radiotherapy combined with concurrent bevacizumab in patients with triple-negative non-metastatic breast cancer. British Journal of Radiology. 88(1048). 20140800–20140800. 9 indexed citations
10.
Belin, Lisa, Paul Cottu, P. Bontemps, et al.. (2014). Radiotherapy associated with concurrent bevacizumab in patients with non-metastatic breast cancer. The Breast. 23(6). 816–820. 6 indexed citations
11.
12.
Estivalet, L., et al.. (2013). Imaging features and follow-up of large extrahepatic portal vein aneurysm. Journal of Vascular Surgery Venous and Lymphatic Disorders. 1(3). 309–310. 1 indexed citations
13.
14.
Maingon, P., Cécile Dalban, Karine Peignaux, et al.. (2012). Does gap-free intensity modulated chemoradiation therapy provide a greater clinical benefit than 3D conformal chemoradiation in patients with anal cancer?. Radiation Oncology. 7(1). 201–201. 25 indexed citations
15.
Créhange, G., X. Montbarbon, P. Pommier, et al.. (2009). Impact of target volumes and radiation technique on loco-regional control and survival for patients with unilateral cervical lymph node metastases from an unknown primary. Radiotherapy and Oncology. 93(3). 483–487. 67 indexed citations
16.
Maingon, P., G. Créhange, Karine Peignaux, & G. Truc. (2008). Place potentielle des thérapies ciblées en association avec la radiothérapie dans les cancers digestifs. Cancer/Radiothérapie. 12(1). 25–30. 1 indexed citations
17.
Naudy, S., Karine Peignaux, G. Créhange, et al.. (2006). Mise en œuvre de la radiothérapie conformationnelle par modulation d'intensité guidée par échographie transabdominale. Cancer/Radiothérapie. 10(6-7). 388–393. 4 indexed citations
18.
Benchalal, M., Pierre Boisselier, B. De Lafontan, et al.. (2006). [Influence of the delay between conservative surgery and radiation therapy on local relapse in node-positive breast tumor].. PubMed. 93(3). 303–13. 1 indexed citations
19.
Maingon, P., et al.. (2005). La radiothérapie de conformation avec et sans modulation d'intensité dans le traitement du cancer localisé de la prostate. Cancer/Radiothérapie. 9(6-7). 382–387. 3 indexed citations
20.
Maingon, P., et al.. (2004). Les contraintes aux organes à risque en radiothérapie par modulation d'intensité des cancers ORL. Cancer/Radiothérapie. 8(4). 234–247. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mauricio Cambeiro Breakdown of academic impact, for papers by Sei‐Chul Yoon Breakdown of academic impact, for papers by Chawalit Lertbutsayanukul Breakdown of academic impact, for papers by Sonali Rudra Breakdown of academic impact, for papers by Subhakar Mutyala Breakdown of academic impact, for papers by John M. Stahl Breakdown of academic impact, for papers by Noriko Ii Breakdown of academic impact, for papers by Sait Okkan Breakdown of academic impact, for papers by Ji Hyeon Joo Breakdown of academic impact, for papers by Gaia Piperno
Rankless by CCL
2026